Oligodendrocyte morphometry and expression of myelin - Related mRNA in ventral prefrontal white matter in major depressive disorder

Journal of Psychiatric Research

Volumn 65, Issue , 2015, Pages 53-62

  Rajkowska, Grazyna ^a   Mahajan, Gouri ^a   Maciag, Dorota ^a   Sathyanesan, Monica ^d   Iyo, Abiye H ^a   Moulana, Mohadetheh ^a   Kyle, Patrick B ^b   Woolverton, William L ^a   Miguel Hidalgo, Jose Javier ^a   Stockmeier, Craig A ^a,c   Newton, Samuel S ^d  

^a Department of Psychiatry and Human Behavior ^*  (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

CNPase; MOG; Myelin; OLIG1; PLP1; Postmortem

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; FLUOXETINE; MESSENGER RNA; MYELIN; MYELIN BASIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; OLIGODENDROCYTE TRANSCRIPTION FACTOR 1; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; PROTEOLIPID PROTEIN; PROTEOLIPID PROTEIN 1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; MYELIN PROTEIN; NERVE PROTEIN; OLIG1 PROTEIN, HUMAN; PLP1 PROTEIN, HUMAN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN TISSUE; CELL DENSITY; CELL SIZE; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MAJOR DEPRESSION; MALE; MORPHOMETRICS; NERVE CELL DEGENERATION; NONHUMAN; OLIGODENDROGLIA; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WHITE MATTER; ANALYSIS OF VARIANCE; ANIMAL; DIFFUSION TENSOR IMAGING; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; RHESUS MONKEY; VERY ELDERLY; YOUNG ADULT;

2',3'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; DEPRESSIVE DISORDER, MAJOR; DIFFUSION TENSOR IMAGING; FEMALE; HUMANS; MACACA MULATTA; MALE; MIDDLE AGED; MYELIN PROTEINS; MYELIN PROTEOLIPID PROTEIN; NERVE TISSUE PROTEINS; OLIGODENDROGLIA; PREFRONTAL CORTEX; RNA, MESSENGER; YOUNG ADULT;

EID: 84929515985     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2015.04.010     Document Type: Article

References (77)

1. Abe O., Yamasue H., Kasai K., Yamada H., Aoki S., Inoue H., et al. Voxel-based analyses of gray/white matter volume and diffusion tensor data in major depression. Psychiatry Res 2010, 181:64-70.
2. Akbarian S., Kim J.J., Potkin S.G., Hetrick W.P., Bunney W.E., Jones E.G. Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients. Arch Gen Psychiatry 1996, 53:425-436.
3. American Psychiatric Association Diagnostic and statistical manual of mental disorders 1994, American Psychiatric Press, Washington, DC. 4th ed.
4. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2013, American Psychiatric Press, Washington, DC. 5th ed.
5. Aston C., Jiang L., Sokolov B.P. Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. Mol Psychiatry 2005, 10:309-322.
6. Baumann N., Pham-Dinh D. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 2001, 81:871-927.
7. Berger T., Reindl M. Multiple sclerosis: disease biomarkers as indicated by pathophysiology. JNeurol Sci 2007, 259:21-26.
8. Bifulco M., Laezza C., Stingo S., Wolff J. 2',3'-Cyclic nucleotide 3'-phosphodiesterase: a membrane-bound, microtubule-associated protein and membrane anchor for tubulin. Proc Natl Acad Sci U. S. A 2002, 99:1807-1812.
9. Carpenter M. Core text of neuroanatomy 1991, Williams & Wilkins, Baltimore. 4th ed.
10. Catani M., Dell'Acqua F., Vergani F., Malik F., Hodge H., Roy P., et al. Short frontal lobe connections of the human brain. Cortex 2012, 48:273-291.
11. Choi K.S., Holtzheimer P.E., Franco A.R., Kelley M.E., Dunlop B.W., Hu X.P., et al. Reconciling variable findings of White matter integrity in major depressive disorder. Neuropsychopharmacology 2014, 39:1332-1339.
12. Copray S., Balasubramaniyan V., Levenga J., de Bruijn J., Liem R., Boddeke E. Olig2 overexpression induces the invitro differentiation of neural stem cells into mature oligodendrocytes. Stem Cells 2006, 24:1001-1010.
13. Davis K.L., Haroutunian V. Global expression-profiling studies and oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 2003, 362:758.
14. Diehl H.J., Schaich M., Budzinski R.M., Stoffel W. Individual exons encode the integral membrane domains of human myelin proteolipid protein. Proc Nat Acad Sci U. S. A 1986, 83:9807-9811.
15. Drevets W.C., Price J.L., Furey M.L. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct 2008, 213:93-118.
16. Du F., Ongür D. Probing myelin and axon abnormalities separately in psychiatric disorders using MRI techniques. Front Integr Neurosci 2013, 7:24.
17. Eastwood S.L., Harrison P.J. Interstitial white matter neuron density in the dorsolateral prefrontal cortex and parahippocampal gyrus in schizophrenia. Schizophr Res 2005, 79:181-188.
18. Edgar N., Sibille E. Aputative functional role for oligodendrocytes in mood regulation. Transl Psychiatry 2012, 2:e109.
19. Farkas N., Lendeckel U., Dobrowolny H., Funke S., Steiner J., Keilhoff G., et al. Reduced density of ADAM 12-immunoreactive oligodendrocytes in the anterior cingulate white matter of patients with schizophrenia. World J Biol Psychiatry 2010, 11:556-566.
20. Filley C.M. The behavioral neurology of white matter 2001, Oxford University Press, New York.
21. First M., Spitzer R., Gibbon M., Williams J. Structured clinical interview for the DSMIV axis I disorders (SCID patient edition), version 2.0 1995, New York State Psychiatric Institute, New York.
22. Fu H., Qi Y., Tan M., Cai J., Takebayashi H., Nakafuku M., et al. Dual origin of spinal oligodendrocyte progenitors and evidence for the cooperative role of Olig2 and Nkx2.2 in the control of oligodendrocyte differentiation. Development 2002, 129:681-693.
23. Garbern J.Y., Yool D.A., Moore G.J., Wilds I.B., Faulk M.W., Klugmann M., et al. Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. Brain 2002, 125:551-561.
24. Gravel M.J., Peterson J., Yong V.W., Kottis V., Trapp B., Braun P.E. Overexpression of 2',3'-cyclic nucleotide 3'-phosphodiesterase in transgenic mice alters oligodendrocyte development and produces aberrant myelination. Mol Cell Neurosci 1996, 1996(7):453-466.
25. Griffiths I., Klugmann M., Anderson T., Yool D., Thomson C., Schwab M.H., et al. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 1998, 280:1610-1613.
26. Hakak Y., Walker J.R., Li C., Wong W.H., Davis K.L., Buxbaum J.D., et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci U. S. A 2001, 98:4746-4751.
27. Hof P.R., Haroutunian V., Friedrich V.L., Byne W., Buitron C., Perl D.P., et al. Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biol Psychiatry 2003, 53:1075-1085.
28. Jbabdi S., Lehman J.F., Haber S.N., Behrens T.E. Human and monkey ventral prefrontal fibers use the same organizational principles to reach their targets: tracing versus tractography. JNeurosci 2013, 33:3190-3201.
29. Joshi D., Fung S.J., Rothwell A., Weickert C.S. Higher gamma-aminobutyric acid neuron density in the white matter of orbital frontal cortex in schizophrenia. Biol Psychiatry 2012, 72:725-733.
30. Karolewicz B., Maciag D., O'Dwyer G., Stockmeier C.A., Feyissa A.M., Rajkowska G. Reduced level of glutamic acid decarboxylase-67 kDa in the prefrontal cortex in major depression. Int J Neuropsychopharmacol 2010, 13:411-420.
31. Kim S., Webster M.J. Correlation analysis between genome-wide expression profiles and cytoarchitectural abnormalities in the prefrontal cortex of psychiatric disorders. Mol Psychiatry 2010, 15:326-336.
32. Klempan T.A., Sequeira A., Canetti L., Lalovic A., Ernst C., ffrench-Mullen J., et al. Altered expression of genes involved in ATP biosynthesis and GABAergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression. Mol Psychiatry 2009, 14:175-189.
33. Koenigs M., Grafman J. The functional neuroanatomy of depression: distinct roles for ventromedial and dorsolateral prefrontal cortex. Behav Brain Res 2009, 201:239-243.
34. Koolschijn P.C., van Haren N.E., Lensvelt-Mulders G.J., Hulshoff Pol H.E., Kahn R.S. Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Hum Brain Mapp 2009, 30:3719-3735.
35. Kringelbach M.L. The human orbitofrontal cortex: linking reward to hedonic experience. Nat Rev Neurosci 2005, 6:691-702.
36. Kringelbach M.L., Rolls E.T. The functional neuroanatomy of the human orbitofrontal cortex: evidence from neuroimaging and neuropsychology. Prog Neurobiol 2004, 72:341-372.
37. Lu Q.R., Sun T., Zhu Z., Ma N., Garcia M., Stiles C.D., et al. Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection. Cell 2002, 109:75-86.
38. Mackey S., Petrides M. Quantitative demonstration of comparable architectonic areas within the ventromedial and lateral orbital frontal cortex in the human and the macaque monkey brains. Eur J Neurosci 2010, 32:1940-1950.
39. Malykhin N., Vahidy S., Michielse S., Coupland N., Camicioli R., Seres P., et al. Structural organization of the prefrontal white matter pathways in the adult and aging brain measured by diffusion tensor imaging. Brain Struct Funct 2011, 216:417-431.
40. Marie Y., Sanson M., Mokhtari K., Leuraud P., Kujas M., Delattre J.Y., et al. OLIG2 as a specific marker of oligodendroglial tumour cells. Lancet 2001, 358:298-300.
41. Miguel-Hidalgo J.J., Waltzer R., Whittom A.A., Austin M.C., Rajkowska G., Stockmeier C.A. Glial and glutamatergic markers in depression, alcoholism, and their comorbidity. JAffect Disord 2010, 127:230-240.
42. Mosebach J., Keilhoff G., Gos T., Schiltz K., Schoeneck L., Dobrowolny H., et al. Increased nuclear Olig1-expression in the pregenual anterior cingulate white matter of patients with major depression: a regenerative attempt to compensate oligodendrocyte loss?. JPsychiatr Res 2013, 47:1069-1079.
43. Murphy M.L., Frodl T. Meta-analysis of diffusion tensor imaging studies shows altered fractional anisotropy occurring in distinct brain areas in association with depression. Biol Mood Anxiety Disord 2011, 1:3-12.
44. Myers-Schulz B., Koenigs M. Functional anatomy of ventromedial prefrontal cortex: implications for mood and anxiety disorders. Mol Psychiatry 2012, 17:132-141.
45. Myllykoski M., Raasakka A., Han H., Kursula P. Myelin 2',3'-cyclic nucleotide 3'-phosphodiesterase: active-site ligand binding and molecular conformation. PLoS One 2012, 7:e32336.
46. Nave K.A. Myelination and support of axonal integrity by glia. Nature 2010, 468:244-252.
47. Nazeri A., Chakravarty M.M., Felsky D., Lobaugh N.J., Rajji T.K., Mulsant B.H., et al. Alterations of superficial white matter in schizophrenia and relationship to cognitive performance. Neuropsychopharmacology 2013, 38:1954-1962.
48. Nobuhara K., Okugawa G., Sugimoto T., Minami T., Tamagaki C., Takase K., et al. Frontal white matter anisotropy and symptom severity of late-life depression: a magnetic resonance diffusion tensor imaging study. JNeurol Neurosurg Psychiatry 2006, 77:120-122.
49. Paxinos G., Huang X.F., Toga A.W. The rhesus monkey brain in stereotaxic Coordinates 2000, Academic Press.
50. Price J.L., Drevets W.C. Neurocircuitry of mood disorders. Neuropsychopharmacology 2010, 35:192-216.
51. Rajkowska G., Hughes J., Stockmeier C.A., Miguel-Hidalgo J., Maciag D. Coverage of blood vessels by astrocytic endfeet is reduced in major depressive disorder. Biol Psychiatry 2013, 73:613-621.
52. Rajkowska G., Miguel-Hidalgo J.J., Dubey P., Stockmeier C.A., Krishnan K.R. Prominent reduction in pyramidal neurons density in the orbitofrontal cortex of elderly depressed patients. Biol Psychiatry 2005, 58:297-306.
53. Rajkowska G., Miguel-Hidalgo J.J., Wei J., Pittman S.D., Dilley G., Overholser J., et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry 1999, 45:1085-1098.
54. Rolls E.T., Grabenhorst F. The orbitofrontal cortex and beyond: from affect to decision-making. Prog Neurobiol 2008, 86:216-244.
55. Roth M.P., Malfroy L., Offer C., Sevin J., Enault G., Borot N., et al. The human myelin oligodendrocyte glycoprotein (MOG) gene: complete nucleotide sequence and structural characterization. Genomics 1995, 28:241-250.
56. Scherer S.S., Braun P.E., Grinspan J., Collarini E., Wang D.Y., Kamholz J. Differential regulation of the 2',3'-cyclic nucleotide 3'-phosphodiesterase gene during oligodendrocyte development. Neuron 1994, 6:1363-1375.
57. Schmahmann J.D., Pandya D.N. Fiber pathways of the brain 2006, Oxford University Press, New York.
58. Segal D., Koschnick J.R., Slegers L.H., Hof P.R. Oligodendrocyte pathophysiology: a new view of schizophrenia. Int J Neuropsychopharmacol 2007, 10:503-511.
59. Sexton C.E., Mackay C.E., Ebmeier K.P. Asystematic review of diffusion tensor imaging studies in affective disorders. Biol Psychiatry 2009, 66:814-823.
60. Shimony J.S., Sheline Y.I., D'Angelo G., Epstein A.A., Benzinger T.L., Mintun M.A., et al. Diffuse microstructural abnormalities of normal-appearing white matter in late life depression: a diffusion tensor imaging study. Biol Psychiatry 2009, 66:245-252.
61. Sibille E., Wang Y., Joeyen-Waldorf J., Gaiteri C., Surget A., Oh S., et al. Amolecular signature of depression in the amygdala. Am J Psychiatry 2009, 166:1011-1024.
62. Song S.K., Sun S.W., Ju W.K., Lin S.J., Cross A.H., Neufeld A.H. Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. Neuroimage 2003, 20:1714-1722.
63. Song S.K., Sun S.W., Ramsbottom M.J., Chang C., Russell J., Cross A.H. Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage 2002, 17:1429-1436.
64. Szewczyk B., Albert P.R., Rogaeva A., Fitzgibbon H., May W.L., Rajkowska G., et al. Decreased expression of Freud-1/CC2D1A, a transcriptional repressor of the 5-HT1A receptor, in the prefrontal cortex of subjects with major depression. IntJ Neuropsychopharmacol 2010, 13:1089-1101.
65. Tham M.W., Woon P.S., Sum M.Y., Lee T.S., Sim K. White matter abnormalities in major depression: evidence from post-mortem, neuroimaging and genetic studies. JAffect Disord 2011, 132:26-36.
66. Tkachev D., Mimmack M.L., Ryan M.M., Wayland M., Freeman T., Jones P.B., et al. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 2003, 362:798-805.
67. Trapp B.D., Bernier L., Andrews S.B., Colman D.R. Cellular and subcellular distribution of 2',3'-cyclic nucleotide 3'-phosphodiesterase and its mRNA in the rat central nervous system. JNeurochem 1988, 51:859-868.
68. Uranova N., Orlovskaya D., Vikhreva O., Zimina I., Kolomeets N., Vostrikov V., et al. Electron microscopy of oligodendroglia in severe mental illness. Brain Res Bull 2001, 55:597-610.
69. Uranova N.A., Vostrikov V.M., Orlovskaya D.D., Rachmanova V.I. Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a studyfrom the Stanley neuropathology Consortium. Schizophr Res 2004, 67:269-275.
70. Uylings H.B., Sanz-Arigita E.J., de Vos K., Pool C.W., Evers P., Rajkowska G. 3-D cytoarchitectonic parcellation of human orbitofrontal cortex correlation with postmortem MRI. Psychiatry Res 2010, 183:1-20.
71. Watanabe M., Sakurai Y., Ichinose T., Aikawa Y., Kotani M., Itoh K. Monoclonal antibody rip specifically recognizes 2',3'-cyclic nucleotide 3'-phosphodiesterase in oligodendrocytes. JNeurosci Res 2006, 84:525-533.
72. Williams M.R., Hampton T., Pearce R.K., Hirsch S.R., Ansorge O., Thom M., et al. Astrocyte decrease in the subgenual cingulate and callosal genu in schizophrenia. Eur Arch Psychiatry Clin Neurosci 2013, 263:41-52.
73. Xin M., Yue T., Ma Z., Wu F.F., Gow A., Lu Q.R. Myelinogenesis and axonal recognition by oligodendrocytes in brain are uncoupled in olig1-null mice. JNeurosci 2005, 25:1354-1365.
74. Yang Y., Fung S.J., Rothwell A., Tianmei S., Weickert C.S. Increased interstitial white matter neuron density in the dorsolateral prefrontal cortex of people with schizophrenia. Biol Psychiatry 2011, 69:63-70.
75. Yeterian E.H., Pandya D.N., Tomaiuolo F., Petrides M. The cortical connectivity of the prefrontal cortex in the monkey brain. Cortex 2012, 48:156-165.
76. Yin X., Peterson J., Gravel M., Braun P.E., Trapp B.D. CNP overexpression induces aberrant oligodendrocyte membranes and inhibits MBP accumulation and myelin compaction. JNeurosci Res 1997, 50:238-247.
77. Yu W.P., Collarini E.J., Pringle N.P., Richardson W.D. Embryonic expression of myelin genes: evidence for a focal source of oligodendrocyte precursors in the ventricular zone of the neural tube. Neuron 1994, 6:1353-1362.